Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters










Publication year range
1.
Genes Immun ; 9(7): 640-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18719603

ABSTRACT

CD154 (CD40-ligand) is a critical immune regulator. CD154 expression is tightly regulated and largely restricted to activated CD4 T cells. Using DNase I hypersensitivity site (HSS) mapping, we identified two novel HSS mapping to the human CD154 promoter element and just upstream. Both HSS were activation independent and CD4 T-cell specific. Approximately 350 bp of DNA sequence flanking the upstream HSS site was highly conserved between mouse and man, and was rich in binding sites for GATA and NFAT proteins. Gel shift and chromatin immunoprecipitation assays demonstrated both NFAT1 and the Th2 factor, GATA-3, bound this enhancer element in vitro and in vivo, respectively. A PstI/XbaI 345 bp fragment of this region acted as a transcriptional enhancer of the CD154 promoter in primary human CD4 T cells. Overexpression of repressor of GATA and a dominant negative GATA-3 protein independently inhibited transcription, whereas overexpression of wild-type GATA-3 enhanced transcriptional activity, by this element in primary CD4 T cells. Moreover, more interleukin-4-producing CD4 T cells expressed CD154 following activation than interferon-gamma-producing CD4 T cells. Thus, we identified a novel T-cell-specific, GATA-3 responsive, CD154 transcriptional enhancer, which may contribute to increased propensity of Th2 cells to express CD154.


Subject(s)
CD40 Ligand/genetics , Enhancer Elements, Genetic/immunology , Epitopes, T-Lymphocyte/immunology , Promoter Regions, Genetic/immunology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Trans-Activators/physiology , Transcription, Genetic , Base Sequence , CD40 Ligand/physiology , Cells, Cultured , Epitopes, T-Lymphocyte/genetics , GATA3 Transcription Factor/physiology , Humans , Jurkat Cells , Molecular Sequence Data , Trans-Activators/genetics , U937 Cells , Up-Regulation/genetics , Up-Regulation/immunology
2.
Neuropharmacology ; 55(5): 729-36, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18616957

ABSTRACT

Adrenomedullin (ADM), a 52-amino acid peptide, elicits differential cardiovascular responses when it is administered systemically or directly to the brain. We evaluated in the present study the hypothesis that ADM may modulate baroreceptor reflex (BRR) response through an ADM receptor-mediated cAMP/ protein kinase A (PKA)-dependent mechanism in the nucleus tractus solitarii (NTS), the terminal site for primary baroreceptor afferents, using Sprague-Dawley rats. Our immunoblot and immunohistochemical results showed that the two component proteins of the ADM(1) receptor complex, calcitonin receptor-like receptor (CRLR) and receptor activity modifying protein (RAMP)-2, were uniformly distributed and highly co-localized in the NTS. Site-specific microinjection of ADM (0.02-0.2pmol) unilaterally into the NTS significantly increased BRR response and sensitivity in a time- and dose-related manner, without affecting arterial pressure and heart rate. The BRR enhancing effect of ADM was also temporally correlated with an up-regulation of PKA(beta), the active form of PKA and an increase in PKA activity. In addition, the ADM-evoked BRR enhancement or PKA activation was abolished by co-microinjection with a selective ADM(1) receptor antagonist, ADM(22-52), an adenylyl cyclase inhibitor, SQ22536, or a PKA inhibitor, Rp-8-bromo-cAMP. These results suggest that ADM enhances BRR via activation of a cAMP/PKA-dependent mechanism by acting site-specifically on ADM(1) receptors in NTS.


Subject(s)
Adrenomedullin/pharmacology , Baroreflex/drug effects , Bronchodilator Agents/pharmacology , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic AMP/metabolism , Signal Transduction/drug effects , Solitary Nucleus/drug effects , 8-Bromo Cyclic Adenosine Monophosphate/analogs & derivatives , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Adenine/analogs & derivatives , Adenine/pharmacology , Analysis of Variance , Animals , Blood Pressure/drug effects , Calcitonin Receptor-Like Protein , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Inhibitors/pharmacology , Heart Rate/drug effects , Intracellular Signaling Peptides and Proteins/metabolism , Male , Membrane Proteins/metabolism , Peptide Fragments/pharmacology , Rats , Rats, Sprague-Dawley , Receptor Activity-Modifying Proteins , Receptors, Calcitonin/metabolism , Solitary Nucleus/metabolism , Thionucleotides/pharmacology , Time Factors
3.
J Immunol ; 167(8): 4414-20, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11591766

ABSTRACT

IL-13, a Th2 cell-specific cytokine, is a major effector molecule mediating several pathological features of allergic asthma. However, the transcriptional regulation of the IL-13 gene remains unclear. Here we demonstrate, by using intracellular cytokine staining, that IL-13 is not always coexpressed with other Th2 cytokines in normal Th cells on a single cell basis. In addition, we identified and cloned a minimal inducible and cell type-specific promoter of the murine IL-13 gene. The cell type specificity of the minimal IL-13 promoter is mediated by a functionally critical GATA-3 site that binds endogenous GATA-3 proteins, whereas the induction by PMA/ionomycin is mediated by distinct cis-acting elements. Furthermore, by expressing GATA-3 in wild-type and c-maf transgenic Th1 cells, we demonstrate that the expression of IL-13 is regulated by a mechanism distinct from that regulating the expression of IL-4, and that the expression of Th1 and Th2 cytokine genes does not have to be mutually exclusive in effector Th cells.


Subject(s)
DNA-Binding Proteins/metabolism , Interleukin-13/genetics , Th2 Cells/immunology , Trans-Activators/metabolism , Animals , Binding Sites , GATA3 Transcription Factor , Mice , Promoter Regions, Genetic , Protein Binding , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-maf , Th1 Cells/immunology , Tissue Distribution , Transcriptional Activation
4.
J Biol Chem ; 276(21): 18321-6, 2001 May 25.
Article in English | MEDLINE | ID: mdl-11278438

ABSTRACT

We report a novel phospholipase A(2) (PLA(2)), group XII (GXII) PLA(2), distinct from other cysteine-rich groups with a catalytic histidine motif, by its 20-kDa size and distribution of the 14 cysteine residues within the protein. Alternative spliced forms with distinct subcellular localization, designated GXII-1 and GXII-2, were identified by reverse transcription-polymerase chain reaction. Importantly, GXII PLA(2)s, in particular GXII-2 PLA(2), and group V PLA(2), but not group X PLA(2), were selectively expressed in murine type 2 helper T (Th2) clones and in vitro differentiated mouse CD4 Th2 cells as compared with type 1 helper T clones and cells. Stimulation with anti-CD3 appreciably up-regulated expression of GXII PLA(2)s and group V PLA(2) by steady state analysis of the Th2 cells as compared with type 1 helper T cells. These results suggest that group XII and group V PLA(2)s might participate in helper T cell immune response through release of immediate second signals and generation of downstream eicosanoids.


Subject(s)
Phospholipases A/genetics , Th2 Cells/enzymology , Alternative Splicing , Amino Acid Sequence , Animals , Cell Line , Cloning, Molecular , Molecular Sequence Data , Phospholipases A/immunology , Phospholipases A/metabolism , Sequence Alignment , Sequence Analysis , Th2 Cells/immunology
5.
Diabetes ; 50(1): 39-46, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11147792

ABSTRACT

Autoimmune diabetes is associated with T helper 1 polarization, but protection from disease can be provided by the application of T helper 2 (Th2) cytokines. To test whether genetic manipulation of T-cells can provide protective Th2 responses, we developed transgenic mice in which T-cells express the interleukin-4-specific transcription factor c-Maf. When crossed with a transgenic model that combines a class II restricted T-cell receptor specific for influenza hemagglutinin with islet beta-cell expression of hemagglutinin, the c-Maf transgene provided significant protection from spontaneous autoimmunity but not from adoptively transferred diabetes. In a second transgenic model in which islet cells express the lymphocytic choriomeningitis virus nucleoprotein, the virus infection triggers autoimmune diabetes within a few weeks involving both CD4 and CD8 T-cells; here too transgenic c-Maf provided significant protection. Surprisingly, when the c-Maf transgene was backcrossed with the NOD model of spontaneous disease, no protection was evident. Thus, transgenic c-Maf can strongly influence autoimmune disease development in some models, but additional factors, such as background genetic differences, can influence the potency of its effect.


Subject(s)
DNA-Binding Proteins/pharmacology , Diabetes Mellitus, Type 1/prevention & control , Proto-Oncogene Proteins/pharmacology , Animals , CD4-Positive T-Lymphocytes/transplantation , Cell Division/drug effects , DNA-Binding Proteins/genetics , Diabetes Mellitus/genetics , Diabetes Mellitus/pathology , Diabetes Mellitus/prevention & control , Diabetes Mellitus/virology , Islets of Langerhans/drug effects , Islets of Langerhans/pathology , Lymphocytic Choriomeningitis , Mice , Mice, Inbred NOD , Mice, Transgenic/genetics , Pancreatitis/pathology , Pancreatitis/prevention & control , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-maf , T-Lymphocytes/cytology , Transgenes/physiology
6.
Mutat Res ; 452(1): 41-50, 2000 Jul 20.
Article in English | MEDLINE | ID: mdl-10894889

ABSTRACT

Numerous reports have shown that oxidative stress is involved in arsenite-induced genetic damage. Arsenite is also a potent inducer of heme oxygenase (HO)-1. To understand whether HO-1 could function as a cellular antioxidant and protect cells from arsenite injury, the effects of tin-protoporphyrin (SnPP), a competitive inhibitor of HO-1, on arsenite-induced genetic damage were examined in human skin fibroblasts (HFW). In the present study, we found that SnPP at 100 microM significantly potentiated arsenite-induced cytotoxicity, DNA strand breaks (assayed by alkaline single cell gel electrophoresis(SCGE)), and chromatid breaks. Although arsenite alone mainly induced kinetochore-plus micronuclei (K(+)-MN), SnPP only synergistically enhanced kinetochore-negative micronuclei (K(-)-MN). The increase in K(-)-MN by SnPP cotreatment was consistent with the increase in DNA strand breaks and chromatid breaks caused by SnPP. However, at higher arsenite doses, K(+)-MN was significantly reduced by SnPP. Pretreatment of HFW cells with hemin, an inducer of HO-1, significantly attenuated the cytotoxicity of arsenite. Therefore, the present results suggest that HO-1 induction by arsenite plays certain roles in protecting cells from arsenite-induced injury.


Subject(s)
Arsenites/pharmacology , Chromosome Aberrations , DNA/drug effects , Fibroblasts/drug effects , Metalloporphyrins/pharmacology , Micronuclei, Chromosome-Defective/drug effects , Protoporphyrins/pharmacology , Cell Survival/drug effects , Cells, Cultured , Comet Assay , DNA/genetics , Dose-Response Relationship, Drug , Drug Synergism , Enzyme Inhibitors/pharmacology , Fibroblasts/cytology , Fibroblasts/metabolism , Heme Oxygenase (Decyclizing)/antagonists & inhibitors , Humans , Infant, Newborn , Kinetochores , Male , Tumor Cells, Cultured
7.
Immunity ; 12(3): 323-33, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10755619

ABSTRACT

GATA-3 is a T cell-specific transcription factor and is essential for the development of the T cell lineage. Recently, it was shown that the expression of GATA-3 is further induced in CD4+ helper T cells upon differentiation into type 2 but not type 1 effector cells. Here, we report the molecular cloning of a GATA-3 interacting protein, repressor of GATA (ROG). ROG is a lymphoid-specific gene and is rapidly induced in Th cells upon stimulation with anti-CD3. In in vitro assays, ROG represses the GATA-3-induced transactivation. Furthermore, overexpression of ROG in Th clones inhibits the production of Th cytokines. Taken together, our results suggest that ROG might play a critical role in regulating the differentiation and activation of Th cells.


Subject(s)
Cytokines/genetics , DNA-Binding Proteins/metabolism , Gene Expression Regulation , Repressor Proteins/metabolism , Trans-Activators/metabolism , Amino Acid Sequence , Animals , Base Sequence , Binding Sites , Chromosome Mapping , Cloning, Molecular , Cytokines/biosynthesis , DNA/metabolism , DNA, Complementary , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/genetics , GATA3 Transcription Factor , Humans , Jurkat Cells , Kruppel-Like Transcription Factors , Lymphocytes/metabolism , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Precipitin Tests , Promyelocytic Leukemia Zinc Finger Protein , Protein Binding , Repressor Proteins/genetics , Th1 Cells/metabolism , Th2 Cells/metabolism , Trans-Activators/antagonists & inhibitors , Trans-Activators/genetics , Transcription Factors/genetics , Transcriptional Activation , Tumor Cells, Cultured , Zinc Fingers
8.
Immunity ; 10(6): 745-51, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10403649

ABSTRACT

IL-4 promotes the differentiation of naive CD4+ T cells into IL-4-producing T helper 2 (Th2) cells. Previous work provided suggestive but not conclusive evidence that the transcription factor c-Maf directed the tissue-specific expression of IL-4. It was not known whether c-Maf controlled the transcription of other Th2 cytokine genes. To elucidate the role of c-Maf in vivo, we examined cytokine production in mice lacking c-Maf (c-maf(-/-)). CD4+ T cells and NK T cells from c-maf(-/-) mice were markedly deficient in IL-4 production. However, the mice produced normal levels of IL-13 and IgE, and, when differentiated in the presence of exogenous IL-4, c-maf(-/-) T cells produced approximately normal levels of other Th2 cytokines. We conclude that c-Maf has a critical and selective function in IL-4 gene transcription in vivo.


Subject(s)
Cytokines/physiology , DNA-Binding Proteins/physiology , Interleukin-4/biosynthesis , Proto-Oncogene Proteins/physiology , Th2 Cells/metabolism , Transcription Factors/physiology , Animals , DNA-Binding Proteins/metabolism , Immunoglobulin E/metabolism , Interleukin-10/genetics , Interleukin-10/metabolism , Interleukin-13/metabolism , Interleukin-4/pharmacology , Interleukin-5/genetics , Interleukin-5/metabolism , Mice , Mice, Inbred BALB C , Mice, Mutant Strains , Promoter Regions, Genetic/physiology , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-maf , Spleen/cytology , Spleen/drug effects , Th2 Cells/immunology , Transcription Factors/metabolism
9.
Toxicol Sci ; 47(2): 176-80, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10220854

ABSTRACT

In this report, we found that arsenite-resistant human lung adenocarcinoma cells, CL3R15, were more susceptible to CuCl2 than the parental CL3 cells. With the aid of atomic absorption spectrophotometry, we observed that CL3R15 cells accumulated more copper than CL3 cells. We further demonstrated that sodium arsenite treatment resulted in a dose-dependent increase of copper accumulation in the parental CL3 cells. In contrast, copper did not alter the levels of intracellular arsenite in CL3 cells treated in combination with sodium arsenite and CuCl2. Pretreatment of CL3 cells with sodium arsenite resulted in a significant increase of copper accumulation and cytotoxicity. These results indicate that intracellular copper accumulation is enhanced by arsenite. However, arsenite-enhanced copper accumulation was not observed in two fibroblastic cells, GM00220 and GM03700, derived from Menkes patients. The Menkes gene encodes a membrane pump responsible for copper exportation. Our results suggest that Menkes protein is a potential target of arsenite.


Subject(s)
Adenocarcinoma/metabolism , Arsenites/toxicity , Copper/metabolism , Enzyme Inhibitors/toxicity , Lung Neoplasms/metabolism , Sodium Compounds/toxicity , Analysis of Variance , Heme Oxygenase (Decyclizing)/antagonists & inhibitors , Humans , Menkes Kinky Hair Syndrome/metabolism , Toxicity Tests , Tumor Cells, Cultured
10.
Int Immunol ; 11(2): 243-7, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10069422

ABSTRACT

IL-4 is a cytokine which can be expressed by a number of cell types including Th2 cells, mast cells and a population of CD4+ NK1.1+ NK T cells. Although phenotypic markers exist for identifying each of these cell types, there is at present no known cell surface marker common to all IL-4-producing cells. Using gene targeting in embryonic stem cells, we have modified the IL-4 locus by knock-in of a transmembrane domain to generate mice that express a membrane-bound form of IL-4 (mIL-4). Flow cytometry using an IL-4-specific mAb allowed the detection of IL-secreting Th2 cells, mast cells and NK T cells from mIL-4 mice. Furthermore, the analysis of immune responses in mIL-4 mice following immunization with anti-CD3 and anti-IgD has allowed us to identify distinct subpopulations of IL-4-producing NK T cells. Thus, the expression of IL-4 in a membrane-bound form provides a novel method for the identification and characterization of IL-4-producing cells.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Gene Targeting , Interleukin-4/biosynthesis , Killer Cells, Natural/immunology , Mast Cells/immunology , Th2 Cells/immunology , Animals , Antibodies, Monoclonal/immunology , Cell Differentiation , Cell Membrane/metabolism , Flow Cytometry , Interleukin-4/genetics , Interleukin-4/immunology , Interleukin-4/metabolism , Mice , Mice, Knockout , Mice, Transgenic
11.
Proc Natl Acad Sci U S A ; 96(7): 3781-5, 1999 Mar 30.
Article in English | MEDLINE | ID: mdl-10097114

ABSTRACT

The vertebrate lens is a tissue composed of terminally differentiated fiber cells and anterior lens epithelial cells. The abundant, preferential expression of the soluble proteins called crystallins creates a transparent, refractive index gradient in the lens. Several transcription factors such as Pax6, Sox1, and L-Maf have been shown to regulate lens development. Here we show that mice lacking the transcription factor c-Maf are microphthalmic secondary to defective lens formation, specifically from the failure of posterior lens fiber elongation. The marked impairment of crystallin gene expression observed is likely explained by the ability of c-Maf to transactivate the crystallin gene promoter. Thus, c-Maf is required for the differentiation of the vertebrate lens.


Subject(s)
Crystallins/genetics , DNA-Binding Proteins/metabolism , Gene Expression Regulation , Lens, Crystalline/physiology , Proto-Oncogene Proteins/metabolism , Proto-Oncogenes , Aging , Animals , Animals, Newborn , Cell Nucleus/metabolism , DNA-Binding Proteins/genetics , Genetic Carrier Screening , Genomic Library , Kidney/metabolism , Lens, Crystalline/abnormalities , Lens, Crystalline/growth & development , Mice , Mice, Inbred DBA , Mice, Knockout , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-maf , Restriction Mapping , Reverse Transcriptase Polymerase Chain Reaction , Transcriptional Activation
13.
Proc Natl Acad Sci U S A ; 95(26): 15537-41, 1998 Dec 22.
Article in English | MEDLINE | ID: mdl-9861004

ABSTRACT

NFAT (nuclear factor of activated T cells) is a family of transcription factors implicated in the control of cytokine and early immune response gene expression. Recent studies have pointed to a role for NFAT proteins in gene regulation outside of the immune system. Herein we demonstrate that NFAT proteins are present in 3T3-L1 adipocytes and, upon fat cell differentiation, bind to and transactivate the promoter of the adipocyte-specific gene aP2. Further, fat cell differentiation is inhibited by cyclosporin A, a drug shown to prevent NFAT nuclear localization and hence function. Thus, these data suggest a role for NFAT transcription factors in the regulation of the aP2 gene and in the process of adipocyte differentiation.


Subject(s)
Adipocytes/physiology , Cell Differentiation , DNA-Binding Proteins/metabolism , Lymphocyte Activation , Nuclear Proteins/metabolism , T-Lymphocytes/physiology , Transcription Factors/metabolism , 3T3 Cells , Adipocytes/cytology , Adipocytes/drug effects , Animals , Cell Differentiation/drug effects , Chloramphenicol O-Acetyltransferase/biosynthesis , Chloramphenicol O-Acetyltransferase/genetics , Cyclosporine/pharmacology , Mice , NFATC Transcription Factors , Promoter Regions, Genetic , Recombinant Proteins/biosynthesis , T-Lymphocytes/immunology , Transfection
14.
J Exp Med ; 188(10): 1859-66, 1998 Nov 16.
Article in English | MEDLINE | ID: mdl-9815263

ABSTRACT

The c-maf protooncogene is a T helper cell type 2 (Th2)-specific transcription factor that activates the interleukin (IL)-4 promoter in vitro. Although it has been postulated that c-maf directs the Th2-specific expression of the IL-4 gene in vivo, direct evidence that c-maf functions during the differentiation of normal, primary T cells is lacking. We now demonstrate that overexpression of c-maf in vivo skews the Th immune response along a Th2 pathway, as evidenced by increased production of Th2 cytokines and the IL-4-dependent immunoglobulins, IgG1 and IgE. The overproduction of IgGl and IgE in the CD4 promoter/c-maf transgenic mice was IL-4 dependent since this was not observed in c-maf transgenic mice bred onto an IL-4-deficient background. Ectopic expression of c-maf in mature Th1 cells did not confer on them the ability to produce IL-4, but did decrease the production of IFN-gamma. The attenuation of Th1 differentiation by c-maf overexpression occurred by a mechanism that was independent of IL-4 and other Th2 cytokines, and could be overcome by IL-12. These studies demonstrate that c-maf promotes Th2 differentiation by IL-4-dependent mechanisms and attenuates Th1 differentiation by Th2 cytokine-independent mechanisms.


Subject(s)
Cell Differentiation/immunology , DNA-Binding Proteins/genetics , Interleukin-4/metabolism , Proto-Oncogene Proteins/genetics , Th1 Cells/immunology , Th2 Cells/immunology , Animals , Gene Expression Regulation/immunology , Immunoglobulins/blood , Interferon-gamma/metabolism , Interleukin-10/metabolism , Mice , Mice, Transgenic , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins c-maf , Spleen/immunology , Trans-Activators/genetics
15.
Immunity ; 9(3): 295-304, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9768749

ABSTRACT

Nuclear factor of activated T cells (NFAT) is a family of four related transcription factors implicated in cytokine and early response gene expression in activated lymphocytes. Here we report that NFAT4, in contrast to NFATp and NFATc, is preferentially expressed in DP thymocytes. Mice lacking NFAT4 have impaired development of CD4 and CD8 SP thymocytes and peripheral T cells as well as hyperactivation of peripheral T cells. The thymic defect is characterized by increased apoptosis of DP thymocytes. The increased apoptosis and hyperactivation may reflect heightened sensitivity to TcR-mediated signaling. Further, mice lacking NFAT4 have impaired production of Bcl-2 mRNA and protein. NFAT4 thus plays an important role in the successful generation and survival of T cells.


Subject(s)
DNA-Binding Proteins/physiology , T-Lymphocytes/cytology , Transcription Factors/physiology , Animals , Apoptosis/genetics , CD4-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/cytology , Cell Differentiation/genetics , Cell Survival/genetics , DNA-Binding Proteins/biosynthesis , Gene Expression/drug effects , Gene Targeting/methods , Genes, bcl-2/genetics , HLA-DP Antigens/analysis , Lymphocyte Activation/drug effects , Lymphocyte Activation/genetics , Lymphocyte Count , Mice , Mice, Inbred BALB C , Mice, Transgenic , NFATC Transcription Factors , Nuclear Proteins/biosynthesis , Nuclear Proteins/physiology , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/physiology , Spleen/cytology , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/physiology , T-Lymphocytes/immunology , T-Lymphocytes/physiology , Thymus Gland/cytology , Thymus Gland/immunology , Transcription Factors/biosynthesis
16.
Mutat Res ; 414(1-3): 15-20, 1998 May 11.
Article in English | MEDLINE | ID: mdl-9630482

ABSTRACT

Titanium dioxide (TiO2) has color properties of extreme whiteness and brightness, is relatively inexpensive, and is extensively used as a white pigment in a variety of materials. TiO2, an effective blocker of ultraviolet light, is frequently added to sunscreens and cosmetic creams. However, the genotoxicity of TiO2 remains to be controversial. In this report, we have demonstrated that TiO2 can be transported into Chinese hamster ovary-K1 (CHO-K1) cells. The effects of TiO2 on induction of sister chromatid exchanges (SCE) and micronuclei (MN) were then studied in these cells. The SCE frequency in CHO-K1 cells treated with TiO2 at a nonlethal dose range (0 to 5 microM) for 24 h was significantly and dose-dependently increased. By the conventional MN assay, TiO2 at the dose ranged from 0 to 20 microM slightly increased the MN frequency in CHO-K1 cells. However, in the cytokinesis-block MN assay, the number of MN per 1000 binucleated cells was significantly and dose-dependently enhanced in CHO-K1 cells treated TiO2 at the same dose range for 24 h. These results suggest that TiO2 is a potential genotoxic agent.


Subject(s)
Micronuclei, Chromosome-Defective/drug effects , Mutagens/toxicity , Sister Chromatid Exchange/drug effects , Sunscreening Agents/toxicity , Titanium/toxicity , Animals , CHO Cells , Cell Survival , Cricetinae
17.
Cancer Res ; 57(22): 5051-9, 1997 Nov 15.
Article in English | MEDLINE | ID: mdl-9371502

ABSTRACT

Arsenite, a unique human carcinogen, induces many types of cytogenetic alterations, such as sister chromatid exchanges, chromosome aberrations, and endoreduplication in a variety of in vivo and in vitro systems. Cytogenetic alterations are frequently associated with cancer development. The purpose of this study was to explore how arsenite induces cytogenetic alterations in human skin fibroblasts (HFW). The present results show that treatment of G2-enriched HFW cells with 5 microM arsenite results in significant delay of cell cycle progression, accumulation of mitotic cells, and prolongation of mitosis. Arsenite-induced G2 and mitotic delay are accompanied by accumulation of cyclin B1 and hyperphosphorylation of cdc2 and Mos proteins. In addition to mitotic delay and prolongation, arsenite treatment also induced out-of-phase centromere separation and alterations of chromosome segregation, such as the appearance of c-metaphase, ball-metaphase, and lagged chromosomes. Unlike spindle poisons, arsenite at the dose range used did not inhibit the spindle fiber formation but conceivably deranges the spindle apparatus. By analyzing the karyotype of established subclones surviving arsenite injury, 18% (8 of 44) showed one chromosome loss, whereas all 26 subclones derived from the untreated cultures were diploid. Furthermore, most arsenite-treated clones manifest prolonged life span (86 +/- 18 population doublings) as compared to those derived from the untreated cultures (44 +/- 11 population doublings). Unfortunately, none became immortal. Collectively, treatment of the G2-enriched HFW cells with arsenite can disturb the mitotic events and subsequently induce chromosome loss.


Subject(s)
Arsenites/pharmacology , Chromosome Deletion , Mitosis/drug effects , Sodium Compounds/pharmacology , CDC2 Protein Kinase/metabolism , Cell Survival/drug effects , Chromosome Aberrations , Cyclin B/metabolism , Cyclin B1 , Fibroblasts/drug effects , G2 Phase/drug effects , G2 Phase/genetics , Humans , Karyotyping , Mitosis/genetics , Oncogene Proteins v-mos/metabolism , Phosphorylation , Spindle Apparatus/drug effects
18.
Curr Opin Immunol ; 9(6): 776-81, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9492977

ABSTRACT

Interleukin-4 is an immunomodulatory cytokine which plays a central role in the regulation of allergic and atopic immune responses. Significant progress has been made in gaining a detailed understanding of the transcriptional regulation of the interleukin-4 gene. The recent identification and characterization of several key transcription factors has helped to elucidate the molecular mechanisms of T helper cell cytokine gene expression.


Subject(s)
Gene Expression Regulation/immunology , Interleukin-4/genetics , T-Lymphocytes/immunology , Animals , Humans , Interleukin-4/immunology , STAT6 Transcription Factor , Trans-Activators/genetics , Transcription Factors/genetics
19.
Mutat Res ; 368(3-4): 165-9, 1996 Jul 05.
Article in English | MEDLINE | ID: mdl-8692222

ABSTRACT

Arsenic, widely distributed throughout our environment, is a well-established human carcinogen. We report here that squalene, a natural fish oil, is a potential agent in the reduction of sodium arsenite-induced sister chromatid exchange (SCE) and micronuclei in Chinese hamster ovary (CHO-K1) cells. Squalene dose-dependently inhibited sodium arsenite-induced SCE. At the highest concentration (160 microM), squalene reduced the SCE frequency from 8.85 to 6.47 SCEs per cell which is very close to the background level (5.82 SCEs per cell). Sodium arsenite dose-dependently induces micronuclei in CHO-K1 cells, and squalene at 80 microM significantly inhibits arsenite-induced micronuclei. However, squalene did not eliminate the killing effects of arsenite on the cells and only slightly decreased intracellular accumulation of arsenic.


Subject(s)
Arsenites/toxicity , Carcinogens/toxicity , Micronuclei, Chromosome-Defective/drug effects , Sister Chromatid Exchange/drug effects , Squalene/pharmacology , Animals , CHO Cells , Cricetinae
20.
Cell ; 85(7): 973-83, 1996 Jun 28.
Article in English | MEDLINE | ID: mdl-8674125

ABSTRACT

The molecular basis for the distinctive cytokine expression of CD4+ T helper 1 (Th1) and T helper 2 (Th2) subsets remains elusive. Here, we report that the proto-oncogene c-maf, a basic region/leucine zipper transcription factor, controls tissue-specific expression of IL-4. c-Maf is expressed in Th2 but not Th1 clones and is induced during normal precursor cell differentiation along a Th2 but not Th1 lineage. c-Maf binds to a c-Maf response element (MARE) in the proximal IL-4 promoter adjacent to a site footprinted by extracts from Th2 but not Th1 clones. Ectopic expression of c-Maf transactivates the IL-4 promoter in Th1 cells, B cells, and nonlymphoid cells, a function that maps to the MARE and Th2-specific footprint. Furthermore, c-Maf acts in synergy with the nuclear factor of activated T cells (NF-ATp) to initiate endogeneous IL-4 production by B cells. Manipulation of c-Maf may alter Th subset ratios in human disease.


Subject(s)
DNA-Binding Proteins/genetics , Interleukin-4/genetics , Proto-Oncogene Proteins/genetics , Animals , B-Lymphocytes/physiology , Base Sequence , Blotting, Northern , CD3 Complex/genetics , Cell Differentiation/genetics , Cells, Cultured/physiology , Chromosome Mapping , Clone Cells/physiology , Cytokines/genetics , DNA Footprinting , DNA, Complementary/genetics , Gene Expression Regulation/physiology , Gene Library , Genetic Complementation Test , Lymphoma/genetics , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Promoter Regions, Genetic/genetics , Proto-Oncogene Mas , Proto-Oncogene Proteins c-maf , Recombinant Proteins/genetics , Repressor Proteins/genetics , Sensitivity and Specificity , Spleen/cytology , T-Lymphocytes, Helper-Inducer/physiology , Transcription, Genetic/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...